| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 748533 | 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole | 0.038506707102734 | 0.45194561 |
| NSC 756169 | GSK317314A | 0.038506707102734 | -0.13114185 |
| NSC 760980 | Null | 0.038506707102734 | -0.038263045 |
| NSC 761834 | (Z)-5-chloro-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one | 0.038506707102734 | -0.30320211 |
| NSC 117915 | 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] | 0.0385067071027343 | 0.16564859 |
| NSC 123461 | Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) | 0.0385067071027343 | -0.061876556 |
| NSC 150311 | 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- | 0.0385067071027343 | 0.14470689 |
| NSC 150862 | BLEOMYCIN FRACTION BLM-HPE | 0.0385067071027343 | 0.35215253 |
| NSC 159631 | Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. | 0.0385067071027343 | 0.19681714 |
| NSC 278631 | 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- | 0.0385067071027343 | 0.33034007 |